Khayat CD

No ORCID on file · 1 paper in corpus

nonrandomized-trial 2025

Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand disease

AJOG global reports ·doi:10.1016/j.xagr.2025.100501

BACKGROUND: Heavy menstrual bleeding is the dominant symptom in girls/women with von Willebrand disease (VWD), affecting ∼80 to 90%. Female patients with VWD are typically diagnosed later than males, despite the disproportionate impact of h…